New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT

Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eighteen… The post New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!